These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26494630)

  • 21. The zebrafish as a novel tool for cardiovascular drug discovery.
    Rocke J; Lees J; Packham I; Chico T
    Recent Pat Cardiovasc Drug Discov; 2009 Jan; 4(1):1-5. PubMed ID: 19149699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zebrafish as a model system for mitochondrial biology and diseases.
    Steele SL; Prykhozhij SV; Berman JN
    Transl Res; 2014 Feb; 163(2):79-98. PubMed ID: 24055494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One step forward: the use of transgenic zebrafish tumor model in drug screens.
    Huang X; Nguyen AT; Li Z; Emelyanov A; Parinov S; Gong Z
    Birth Defects Res C Embryo Today; 2011 Jun; 93(2):173-81. PubMed ID: 21671356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissection of cardiovascular development and disease pathways in zebrafish.
    Chan J; Mably JD
    Prog Mol Biol Transl Sci; 2011; 100():111-53. PubMed ID: 21377626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flight for fish in drug discovery: a review of zebrafish-based screening of molecules.
    Dash SN; Patnaik L
    Biol Lett; 2023 Aug; 19(8):20220541. PubMed ID: 37528729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diving into drug-screening: zebrafish embryos as an in vivo platform for antimicrobial drug discovery and assessment.
    Habjan E; Schouten GK; Speer A; van Ulsen P; Bitter W
    FEMS Microbiol Rev; 2024 May; 48(3):. PubMed ID: 38684467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Overview of Zebrafish Modeling Methods in Drug Discovery and Development.
    Larijani B; Hamidpour SK; Tayanloo-Beik A; Shahbazbadr A; Yavari H; Namazi N; Biglar M; Arjmand B
    Adv Exp Med Biol; 2022; 1387():145-169. PubMed ID: 34961915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.
    Liu H; Wang J; Zhou W; Wang Y; Yang L
    J Ethnopharmacol; 2013 Apr; 146(3):773-93. PubMed ID: 23415946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.
    Bootorabi F; Manouchehri H; Changizi R; Barker H; Palazzo E; Saltari A; Parikka M; Pincelli C; Aspatwar A
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lure of zebrafish in liver research: regulation of hepatic growth in development and regeneration.
    Cox AG; Goessling W
    Curr Opin Genet Dev; 2015 Jun; 32():153-61. PubMed ID: 25863341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries.
    Lessman CA
    Birth Defects Res C Embryo Today; 2011 Sep; 93(3):268-80. PubMed ID: 21932435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine.
    Angom RS; Nakka NMR
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zebrafish disease models in hematology: Highlights on biological and translational impact.
    Zizioli D; Mione M; Varinelli M; Malagola M; Bernardi S; Alghisi E; Borsani G; Finazzi D; Monti E; Presta M; Russo D
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):620-633. PubMed ID: 30593895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial: Herbal Medicine on High Impact Disease: The Current Progress and Application.
    Wang Y; Ji G; Zhu L
    Curr Pharm Des; 2017; 23(34):5075-5076. PubMed ID: 29457762
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ideas and methods of two-dimensional zebrafish model combined with chromatographic techniques in high-throughput screening of active anti-osteoporosis components of traditional Chinese medicines].
    Wei YJ; Jing LJ; Zhan Y; Sun E; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1739-42. PubMed ID: 25095395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-endpoint in vivo larval zebrafish (Danio rerio) model for the assessment of integrated cardiovascular function.
    Parker T; Libourel PA; Hetheridge MJ; Cumming RI; Sutcliffe TP; Goonesinghe AC; Ball JS; Owen SF; Chomis Y; Winter MJ
    J Pharmacol Toxicol Methods; 2014; 69(1):30-8. PubMed ID: 24140389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research on distribution of patents' holders for Chinese herbal compounds in treating cardiovascular and cerebrovascular based on cluster analysis].
    YANG XJ; XIAO SY
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(18):3682-6. PubMed ID: 26983221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease.
    Tao W; Xu X; Wang X; Li B; Wang Y; Li Y; Yang L
    J Ethnopharmacol; 2013 Jan; 145(1):1-10. PubMed ID: 23142198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of the zebrafish model in the discovery of bioactive molecules from nature.
    Mandrekar N; Thakur NL
    Biotechnol Lett; 2009 Feb; 31(2):171-9. PubMed ID: 18931972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review.
    Chen Y; Zhu J
    J Viral Hepat; 2013 Jul; 20(7):445-52. PubMed ID: 23730837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.